查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1504053

皮膚科設備市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、治療、地區和競爭細分，2019-2029F

Dermatology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Treatment, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年全球皮膚科設備市場估值為 61.5 億美元，預計在預測期內將強勁成長，到 2029 年複合年成長率為 12.50%。和各種皮膚病的管理。這些設備適用於從皮膚癌診斷到美容治療的廣泛皮膚病治療。

市場概況
預測期 2025-2029
2023 年市場規模 61.5億美元
2029 年市場規模 125億美元
2024-2029 年複合年成長率 12.50%
成長最快的細分市場 皮膚癌
最大的市場 北美洲

這個市場的主要驅動力是全球皮膚疾病的日益流行，而污染、紫外線輻射暴露、生活方式的改變和遺傳傾向等因素推動了這個市場的發展。此外，對解決皮膚老化和美觀問題的微創美容手術的需求不斷成長，也極大地促進了市場成長。技術進步，例如將人工智慧 (AI) 和機器學習 (ML) 演算法整合到皮膚科設備中以提高診斷準確性和治療效果，正在推動市場成長。此外，越來越多採用非侵入性和微創手術，以及綜合護膚解決方案的聯合療法的日益普及，都是塑造市場格局的重要趨勢。

主要市場促進因素

皮膚病的盛行率不斷增加

對微創手術的需求不斷成長

皮膚科設備的技術進步

主要市場挑戰

監理合規和核准流程

皮膚科設備成本高

報銷挑戰

主要市場趨勢

轉向非侵入性和微創手術

人工智慧 (AI) 和機器學習 (ML) 技術的整合

遠距醫療和遠端監控解決方案的採用不斷增加

細分市場洞察

應用洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球皮膚科設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（成像設備、皮膚鏡、顯微鏡）
    • 按應用（皮膚癌診斷、其他）
    • 依治療方式（光療設備、雷射、電外科設備、抽脂設備、微晶煥膚設備、冷凍治療設備）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖

第 6 章：北美皮膚科設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按治療
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲皮膚科設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按治療
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區皮膚科設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按治療
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲皮膚科設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按治療
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲皮膚科設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按申請
    • 按治療
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 13 章：全球皮膚科設備市場：SWOT 分析

第14章：競爭格局

  • Cutera Inc.
  • Cynosure, LLC
  • Lumenis Be Ltd.
  • Alma Lasers
  • Candela Corporation
  • AVITA Medical, Inc.
  • Genesis Biosystems
  • Galderma SA
  • Bausch Health Companies Inc
  • 3Gen, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 7579

Global Dermatology Devices Market was valued at USD 6.15 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 12.50% through 2029. The Dermatology Devices Market encompasses a wide array of medical devices utilized in the diagnosis, treatment, and management of various dermatological conditions. These devices cater to a broad spectrum of dermatological procedures, ranging from skin cancer diagnosis to cosmetic treatments.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 6.15 Billion
Market Size 2029USD 12.50 Billion
CAGR 2024-202912.50%
Fastest Growing SegmentSkin cancer
Largest MarketNorth America

The market is primarily driven by the increasing prevalence of skin disorders globally, fueled by factors such as pollution, UV radiation exposure, changing lifestyles, and genetic predispositions. Additionally, the growing demand for minimally invasive cosmetic procedures to address skin aging and aesthetic concerns contributes significantly to market growth. Technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML) algorithms in dermatology devices for enhanced diagnostic accuracy and treatment outcomes, are driving market growth. Moreover, the increasing adoption of non-invasive and minimally invasive procedures, along with the rising popularity of combination therapies for comprehensive skincare solutions, are significant trends shaping the market landscape.

Key Market Drivers

Increasing Prevalence of Skin Disorders

Environmental factors such as pollution, exposure to UV radiation, and climate change contribute to the rising incidence of skin disorders worldwide. Urbanization and industrialization lead to increased pollution levels, which can exacerbate skin conditions such as acne, eczema, and dermatitis. Additionally, prolonged exposure to UV radiation from sunlight or artificial sources increases the risk of developing skin cancers and other sun-related skin disorders. Modern lifestyle factors such as sedentary habits, unhealthy dietary patterns, and high-stress levels contribute to the prevalence of skin disorders. Poor dietary choices and lack of physical activity can lead to obesity, which is associated with various dermatological conditions such as psoriasis and atopic dermatitis. Moreover, stress and inadequate sleep can trigger inflammatory responses in the skin, worsening existing skin conditions or leading to the development of new ones.

The global aging population is more susceptible to certain skin disorders, including wrinkles, age spots, and skin cancers. Age-related changes in skin structure and function, such as reduced collagen production and diminished elasticity, increase the risk of developing dermatological conditions. As the elderly population grows, there is a corresponding rise in the demand for dermatology devices that address age-related skin concerns, such as anti-aging treatments and skin cancer diagnostics. Genetic factors play a significant role in the development of many skin disorders, including psoriasis, eczema, and acne. Individuals with a family history of these conditions are more likely to experience them themselves. The prevalence of genetic predispositions combined with environmental triggers contributes to the increasing incidence of skin disorders globally.

The increasing prevalence of skin disorders is a key driver fueling the growth of the global Dermatology Devices Market. Environmental factors, lifestyle changes, an aging population, and genetic predispositions all contribute to the rising demand for dermatological treatments and diagnostic solutions provided by dermatology devices. As the burden of skin disorders continues to escalate, the market for dermatology devices is expected to expand to meet the growing needs of patients and healthcare providers worldwide.

Growing Demand for Minimally Invasive Procedures

Patients increasingly prefer minimally invasive procedures over traditional surgical interventions due to several advantages. Minimally invasive procedures typically involve smaller incisions, resulting in less scarring, reduced pain, and shorter recovery times compared to invasive surgeries. Patients appreciate the minimal downtime associated with these procedures, allowing them to return to their daily activities more quickly.

There is a growing emphasis on aesthetics and personal appearance, driving the demand for minimally invasive cosmetic procedures. Patients seek treatments to address signs of aging, such as wrinkles, fine lines, and sagging skin, as well as skin imperfections like acne scars and pigmentation issues. Minimally invasive dermatological procedures, such as laser skin resurfacing, dermal fillers, and botulinum toxin injections, offer effective solutions with minimal discomfort and downtime. Technological innovations in dermatology devices have expanded the range of minimally invasive procedures available to patients. Advanced laser systems, radiofrequency devices, and energy-based platforms enable dermatologists to perform a variety of skin rejuvenation, tightening, and contouring treatments with precision and efficacy. These devices offer customizable treatment options tailored to individual patient needs, driving patient satisfaction and demand for minimally invasive procedures.

Minimally invasive procedures are generally considered safer and less risky than traditional surgical interventions, making them attractive options for both patients and healthcare providers. Dermatology devices used in minimally invasive procedures undergo rigorous testing and regulatory scrutiny to ensure safety and efficacy. Patients can undergo these procedures with confidence, knowing that they are receiving proven treatments with minimal risks of complications. As the global population ages, there is a growing demand for anti-aging treatments and procedures to address age-related skin concerns. Minimally invasive dermatological procedures offer effective solutions for age-related skin issues, such as wrinkles, age spots, and skin laxity, without the need for extensive surgery. The aging population drives demand for dermatology devices that enable minimally invasive procedures to rejuvenate and enhance the appearance of aging skin.

The growing demand for minimally invasive procedures is a key driver fueling the growth of the global Dermatology Devices Market. Patient preference for less invasive treatments, cosmetic concerns, technological advancements, safety considerations, and the aging population collectively contribute to the increasing adoption of minimally invasive dermatological procedures and the demand for dermatology devices that facilitate these treatments.

Technological Advancements in Dermatology Devices

Technological advancements in dermatology devices play a pivotal role in driving the growth of the global Dermatology Devices Market. These advancements encompass various innovations in device design, functionality, and performance, which enhance the diagnosis, treatment, and management of dermatological conditions. Technological advancements enable dermatology devices to deliver more precise and targeted treatments, resulting in improved efficacy and patient outcomes. For example, advanced laser systems and energy-based devices offer customizable treatment parameters, allowing dermatologists to tailor therapies to individual patient needs and specific skin conditions. This precision enhances treatment effectiveness and patient satisfaction, driving demand for dermatology devices that deliver superior outcomes.

Innovations in device technology aim to minimize patient discomfort during dermatological procedures. For instance, the development of cooling mechanisms, built-in anesthesia delivery systems, and contact skin cooling devices help alleviate pain and discomfort associated with certain treatments, such as laser therapy and intense pulsed light (IPL) procedures. By enhancing patient comfort, these technological advancements contribute to increased patient acceptance of dermatological interventions and drive market growth. Technological advancements in dermatology devices have led to the development of new treatment modalities and expanded treatment options for various dermatological conditions. For example, photodynamic therapy (PDT) devices utilize photosensitizing agents and light-based technology to treat precancerous lesions, acne, and other skin disorders. Additionally, innovations in radiofrequency devices, microneedling systems, and ultrasound technology have broadened the scope of dermatological treatments available to patients, driving demand for advanced dermatology devices.

Advanced imaging technologies and diagnostic tools incorporated into dermatology devices enable more accurate and comprehensive assessments of skin conditions. High-resolution imaging systems, such as dermatoscopes and reflectance confocal microscopy (RCM), provide detailed visualization of skin lesions and abnormalities, aiding in the early detection of skin cancer and other dermatological diseases. By improving diagnostic accuracy and facilitating early intervention, these technological advancements contribute to better patient outcomes and drive market growth. The integration of AI and ML algorithms into dermatology devices enhances diagnostic accuracy, treatment planning, and patient management. AI-powered image analysis software can analyze skin images, identify patterns, and assist dermatologists in diagnosing skin conditions with high accuracy. ML algorithms can also optimize treatment parameters based on patient data and treatment outcomes, leading to more personalized and effective therapies. The incorporation of AI and ML technologies into dermatology devices improves clinical decision-making, streamlines workflow efficiency, and enhances overall patient care, driving the adoption of advanced dermatology devices in the market.

Technological advancements in dermatology devices significantly contribute to market growth by enhancing treatment efficacy, minimizing treatment discomfort, expanding treatment options, improving diagnostic capabilities, and integrating AI and ML technologies. These advancements drive innovation, improve patient outcomes, and foster greater adoption of dermatology devices among healthcare providers and patients globally.

Key Market Challenges

Regulatory Compliance and Approval Process

The significant challenges facing the Dermatology Devices Market is navigating the complex regulatory landscape and obtaining regulatory approvals for new devices. Regulatory agencies, such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, impose stringent requirements for the approval of dermatology devices. Compliance with these regulations involves extensive testing, documentation, and clinical trials to demonstrate the safety and efficacy of the devices. The lengthy and costly approval process can delay market entry for manufacturers and hinder innovation in the development of new dermatology devices.

High Cost of Dermatology Devices

The Challenge of the high cost associated with dermatology devices, including acquisition costs, maintenance expenses, and training requirements. Advanced technologies and sophisticated features incorporated into these devices contribute to their high price tags. The substantial upfront investment required to purchase dermatology devices may deter healthcare facilities, particularly smaller clinics and practices, from adopting new technologies. Moreover, ongoing maintenance and servicing costs add to the financial burden, limiting the affordability and accessibility of dermatology devices for healthcare providers.

Reimbursement Challenges

Reimbursement policies and coverage limitations pose significant challenges for the adoption of dermatology devices. In many healthcare systems, reimbursement rates for dermatological procedures and device usage may be inadequate or inconsistent, leading to financial disincentives for healthcare providers. Additionally, certain dermatological treatments and procedures may not be reimbursed by insurance companies or government payers, particularly if they are considered cosmetic in nature. The lack of sufficient reimbursement can impact the financial viability of dermatology practices and hinder investment in advanced dermatology devices. Addressing reimbursement challenges and advocating for improved coverage for dermatological procedures are essential for promoting the widespread adoption of dermatology devices and driving market growth.

Key Market Trends

Shift Towards Non-Invasive and Minimally Invasive Procedures

There is a growing trend towards non-invasive and minimally invasive dermatological procedures, driven by increasing patient preference for less invasive treatments with minimal downtime and fewer side effects. Advanced dermatology devices, such as laser systems, radiofrequency devices, and energy-based platforms, offer a wide range of non-invasive and minimally invasive treatment options for various skin conditions, including wrinkles, scars, pigmentation disorders, and vascular lesions. Patients seek these treatments to achieve cosmetic enhancements, skin rejuvenation, and therapeutic benefits without the need for surgery or extensive recovery periods. The demand for non-invasive and minimally invasive procedures is expected to continue to rise, fueling the adoption of advanced dermatology devices and driving market growth.

Integration of Artificial Intelligence (AI) and Machine Learning (ML) Technologies

The integration of AI and ML technologies into dermatology devices is a significant trend shaping the future of the market. AI-powered image analysis software and ML algorithms enhance diagnostic accuracy, treatment planning, and patient management in dermatology. These technologies enable automated analysis of skin images, identification of patterns and anomalies, and generation of personalized treatment recommendations based on patient data and clinical insights. Dermatology devices equipped with AI and ML capabilities streamline workflow efficiency, improve clinical decision-making, and optimize treatment outcomes, leading to better patient care and enhanced practice efficiency. The adoption of AI and ML technologies in dermatology devices is expected to grow rapidly, driving innovation and market expansion in the coming years.

Rising Adoption of Telemedicine and Remote Monitoring Solutions

The COVID-19 pandemic has accelerated the adoption of telemedicine and remote monitoring solutions in dermatology, leading to a shift towards virtual consultations and remote patient management. Dermatology devices equipped with telemedicine capabilities, such as high-resolution cameras and secure communication platforms, enable dermatologists to conduct virtual consultations, diagnose skin conditions remotely, and monitor patient progress over time. These technologies offer convenience, accessibility, and continuity of care for patients, particularly those in remote or underserved areas. The increasing adoption of telemedicine and remote monitoring solutions in dermatology is expected to drive the demand for dermatology devices with integrated telemedicine features, facilitating remote consultations, tele dermatology services, and digital health initiatives globally.

Segmental Insights

Application Insights

Based on the category of Application, the Skin Cancer Diagnosis segment emerged as the dominant player in the global market for dermatology devices in 2023. Skin cancer is one of the most common types of cancer globally, with a rising incidence observed in recent years. Factors such as prolonged sun exposure, UV radiation, genetic predisposition, and lifestyle habits contribute to the development of skin cancer. As the incidence of skin cancer continues to increase, there is a growing demand for advanced dermatology devices for its diagnosis, treatment, and management. Dermatology devices play a crucial role in the early detection of skin cancer lesions, facilitating prompt intervention and improved patient outcomes.

Technological advancements in dermatology devices have revolutionized the diagnosis and treatment of skin cancer. Advanced imaging techniques, such as dermoscopy, confocal microscopy, and optical coherence tomography (OCT), enable dermatologists to visualize skin lesions with high resolution and accuracy. These imaging modalities aid in the early detection of skin cancer, differentiation of benign and malignant lesions, and assessment of tumor margins. Additionally, dermatology devices, such as laser systems, cryotherapy devices, and surgical instruments, offer a wide range of treatment options for skin cancer, including excision, photodynamic therapy (PDT), and Mohs micrographic surgery. The availability of innovative dermatology devices enhances the efficiency and efficacy of skin cancer diagnosis and treatment, driving market growth in the Skin Cancer segment. Increasing awareness about the importance of skin cancer prevention, early detection, and screening initiatives contribute to the dominance of the Skin Cancer segment in the Dermatology Devices Market. Public health campaigns, educational programs, and screening initiatives raise awareness about the risk factors associated with skin cancer and encourage regular skin examinations for early detection. Dermatology practices, clinics, and healthcare facilities invest in advanced dermatology devices to support skin cancer screening programs and provide comprehensive diagnostic and therapeutic services to patients. The emphasis on early detection and intervention in skin cancer management drives the demand for dermatology devices tailored to skin cancer diagnosis, treatment, and surveillance. These factors are expected to drive the growth of this segment.

Regional Insights

North America emerged as the dominant region in the global dermatology devices market in 2023, holding the largest market share in terms of value. North America boasts a highly developed healthcare infrastructure and technological ecosystem, characterized by state-of-the-art medical facilities, research institutions, and pharmaceutical companies. The region's robust healthcare system facilitates the adoption and utilization of advanced dermatology devices for diagnosis, treatment, and management of various skin conditions. Dermatology practices, clinics, and hospitals in North America are well-equipped with a wide range of dermatology devices, including lasers, imaging systems, cryotherapy devices, and surgical instruments, to meet the growing demand for dermatological services.

North America experiences a high prevalence of skin conditions and skin cancer, driven by factors such as sun exposure, aging population, and lifestyle habits. Skin cancer is one of the most common types of cancer in the region, with melanoma and non-melanoma skin cancers being particularly prevalent. The increasing incidence of skin conditions and skin cancer necessitates the use of advanced dermatology devices for early detection, diagnosis, and treatment. Dermatologists in North America rely on cutting-edge technologies and innovative devices to provide timely and effective care to patients, driving market growth in the region. North America is a global hub for biomedical research, innovation, and technology development in healthcare. Pharmaceutical companies, medical device manufacturers, and research institutions in the region invest heavily in research and development to advance dermatology devices and technologies. These investments fuel innovation in areas such as imaging, laser therapy, phototherapy, and minimally invasive procedures, driving the evolution of dermatology devices and expanding their applications. The continuous introduction of new and improved dermatology devices strengthens North America's position as a leader in the Global Dermatology Devices Market and drives market growth through technological innovation.

Key Market Players

Cutera Inc.

Cynosure, LLC

Lumenis Be Ltd.

Alma Lasers

Candela Corporation

AVITA Medical, Inc.

Genesis Biosystems

Galderma SA

Bausch Health Companies Inc

3Gen, Inc.

Report Scope:

In this report, the Global Dermatology Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatology Devices Market, By Type:

    Imaging Devices Dermatoscopes Microscopes

Dermatology Devices Market, By Application:

    Skin Cancer Diagnosis Other

Dermatology Devices Market, By Treatment:

    Light Therapy Devices Lasers Electrosurgical Equipment Liposuction Devices Microdermabrasion Devices Cryotherapy Devices

Dermatology Devices Market, By Region:

    North America
    • United States
    • Canada
    • Mexico
    Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
    Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    South America
    • Brazil
    • Argentina
    • Colombia
    Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatology Devices Market.

Available Customizations:

Global Dermatology Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermatology Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Imaging Devices, Dermatoscopes, Microscopes)
    • 5.2.2. By Application (Skin Cancer Diagnosis, Other)
    • 5.2.3. By Treatment (Light Therapy Devices, Lasers, Electrosurgical Equipment, Liposuction Devices, Microdermabrasion Devices, Cryotherapy Devices)
    • 5.2.4. By Region
    • 5.2.5. By Company (2023)
  • 5.3. Market Map

6. North America Dermatology Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Treatment
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dermatology Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Treatment
    • 6.3.2. Canada Dermatology Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Treatment
    • 6.3.3. Mexico Dermatology Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Treatment

7. Europe Dermatology Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Treatment
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Dermatology Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Treatment
    • 7.3.2. United Kingdom Dermatology Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Treatment
    • 7.3.3. Italy Dermatology Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Treatment
    • 7.3.4. France Dermatology Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Treatment
    • 7.3.5. Spain Dermatology Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Treatment

8. Asia-Pacific Dermatology Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Treatment
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Dermatology Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Treatment
    • 8.3.2. India Dermatology Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Treatment
    • 8.3.3. Japan Dermatology Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Treatment
    • 8.3.4. South Korea Dermatology Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Treatment
    • 8.3.5. Australia Dermatology Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Treatment

9. South America Dermatology Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Treatment
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Dermatology Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Treatment
    • 9.3.2. Argentina Dermatology Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Treatment
    • 9.3.3. Colombia Dermatology Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Treatment

10. Middle East and Africa Dermatology Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Treatment
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Dermatology Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Treatment
    • 10.3.2. Saudi Arabia Dermatology Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Treatment
    • 10.3.3. UAE Dermatology Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Treatment

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Dermatology Devices Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Cutera Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. Cynosure, LLC
  • 14.3. Lumenis Be Ltd.
  • 14.4. Alma Lasers
  • 14.5. Candela Corporation
  • 14.6. AVITA Medical, Inc.
  • 14.7. Genesis Biosystems
  • 14.8. Galderma SA
  • 14.9. Bausch Health Companies Inc
  • 14.10. 3Gen, Inc.

15. Strategic Recommendations

16.About Us & Disclaimer